Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2005
10/19/2005EP1586371A1 Encapsulation of oxygen sensitive agents
10/19/2005EP1586349A1 Controlled release of anti-arrhythmic agents
10/19/2005EP1586347A1 Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability
10/19/2005EP1586334A1 G-CSF conjugates with peg
10/19/2005EP1586329A1 Botulinum toxin pharmaceutical compositions
10/19/2005EP1586316A1 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
10/19/2005EP1586315A1 Skin lightening composition
10/19/2005EP1586314A1 Nateglinide tablet composition
10/19/2005EP1586312A1 Agent for dissolving dental calculi and dental caries
10/19/2005EP1586309A1 Polymeric delivery formulations of leuprolide with improved efficacy
10/19/2005EP1585817A2 Conjugates comprising a biodegradable polymer and uses therefor
10/19/2005EP1585771A1 Complexes of protein crystals and ionic polymers
10/19/2005EP1585751A2 Peptide deformylase activated prodrugs
10/19/2005EP1585548A2 Compositions and methods of delivery of pharmacological agents
10/19/2005EP1585546A2 Kim-1 antagonists and use to modulate immune system
10/19/2005EP1585542A2 Immunogenic compositions containing phospholipid
10/19/2005EP1585538A1 Modified hemoglobin and methods of making same
10/19/2005EP1585528A1 Use of sphingomyelin and lyso-sphingomyelin as absorption enhancers
10/19/2005EP1585519A1 High concentration formulations of opioids and opioid derivatives
10/19/2005EP1585504A2 Protein-stabilized liposomal formulations of pharmaceutical agents
10/19/2005EP1585503A2 Improved oral delivery of peptides
10/19/2005EP1487272B1 Choline-silicic acid complex with osmolytes and divalent trace elements
10/19/2005EP1439830B1 Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
10/19/2005EP1339438B1 Preventing transplant rejection in the eye
10/19/2005EP1322597A4 Process and intermediates
10/19/2005EP1292618B1 Vip-related peptides for the treatment of sexual disorders in women
10/19/2005EP1292340B1 Transfection system
10/19/2005EP1273299B1 Minoxidil-containing preparations
10/19/2005EP1269972B1 Hair growth stimulant compositions with sustained action
10/19/2005EP1250138B1 Fulvestrant formulation
10/19/2005EP1237539B1 Oral solution containing galanthamine and a sweetening agent
10/19/2005EP1216059B1 Composition for ivf
10/19/2005EP1173217B1 Enhanced delivery of nucleic acid-based drugs
10/19/2005EP1165055B1 Pharmaceutical composition containing estradiol or ethinylestradiol and an extrusion additive
10/19/2005EP1131056B1 Particles based on polyamino-acid(s) and methods for preparing same
10/19/2005EP1104482B1 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins
10/19/2005EP1100541B1 Hydrogel for the therapeutic treatment of aneurysms
10/19/2005EP1036057B1 Radio-opaque polymer biomaterials
10/19/2005EP0814774B1 Reduction of adhesions using controlled delivery of active oxygen inhibitors
10/19/2005EP0771208B1 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells
10/19/2005CN1685037A New mutant strains of pseudomonas fluorescens and variants thereof, methods for their production, and uses thereof in alginate production
10/19/2005CN1684972A Conjugates comprised of polymer and HIV gp41-derived peptides and their use in therapy
10/19/2005CN1684757A Compound consisting of precipitated silica and phosphate and use thereof as nutrient intake liquid support and as anti-caking agent with nutrient intake
10/19/2005CN1684709A Medicine carrier for local application
10/19/2005CN1684703A Administration form for pharmaceutically active peptides with sustained release and method for the production thereof
10/19/2005CN1684691A Formulation for lipophilic agents
10/19/2005CN1684688A Stable eye lotion containing latanoprost as active ingredient
10/19/2005CN1684681A Bicifadine formulation
10/19/2005CN1684673A Electrospun amorphous pharmaceutical compositions
10/19/2005CN1684669A Compositions comprising HMG-CoA reductase inhibitor
10/19/2005CN1684664A Injectable growth promoting and anthelmintic composition
10/19/2005CN1684663A Injectable multimodal polymer depot compositions and uses thereof
10/19/2005CN1684641A Apparatus and method for delivery of mitomycin through an eluting biocompatible implantable medical device
10/19/2005CN1684593A Enzyme preparation and process for producing food using the same
10/19/2005CN1684582A Improved synthesis of polyanhydrides
10/19/2005CN1683447A Encapsulation of oxygen sensitive agents
10/19/2005CN1683414A Process for preparing stereo arrested amine nitrogen oxygen free redical with hydrotalcite analog as catalyst
10/19/2005CN1683016A Process for preparing medicine-carrying particle containing surface transferrin for glioma target chemical therapy
10/19/2005CN1683015A Polyvidone-phospholipid-cholate ternary composition used for difficult soluble medicine carrier
10/19/2005CN1683014A Process for preparig dentritic poly lysine derivative carrier for gene therapy
10/19/2005CN1682745A Nano capsule containing glycyrrhizic acid medicine and its preparing method
10/19/2005CN1682743A Pharmaceutical formulations
10/19/2005CN1682726A Inclusion containing raltitrexed and preparation
10/19/2005CN1682725A Inclusion containing raltitrexed and its powder injection
10/19/2005CN1682707A Pharmaceutical composition comprising fenofibrate and process for its preparation
10/19/2005CN1682704A Levodopa nano preparation and its preparing method
10/19/2005CN1682700A Beta-cyclodextrin/phenylpropanol inclusion and its preparing method
10/19/2005CN1682695A Method for promoting liposome lymph absorption and reducing normal lymph node accumulation
10/19/2005CN1682693A In site gel medicine transfer system for hardening treating angioma and vascular deformity
10/19/2005CN1223378C Cyclodextrin containing glycopeptides antibiotic pharmaceutical compositions
10/19/2005CN1223375C Heat resisting lyophilized protectant for chicken infectious bronchitis H120, H52, Kidney infectious bronchitis W93 lyophilized vaccine and preparing process thereof
10/19/2005CN1223352C Liposome ointment containing heparin kind medicine and its preparation method
10/19/2005CN1223347C Aqueous cilostazol preparation for injection
10/19/2005CN1223342C Sucrose ester-C20-28 alcohol preparation
10/19/2005CN1223340C Electrospun pharmaceutical compositions
10/19/2005CN1223339C Implanted degradable high molecular material medicine control-release carrier and its preparing process
10/19/2005CN1223338C Cetirizine hydrochloride gel
10/18/2005US6956144 Mixture with flow control agents; antiulcer agents
10/18/2005US6956139 (1R, 2S, 5R)-3-1-menthoxyalkan-1-OL cooling sensate
10/18/2005US6956119 Polypeptides; immunoassay using antibodies
10/18/2005US6956062 Storage-stable compositions of glycerol monoalkyl ethers
10/18/2005US6956051 amphiphilic drug-oligomer conjugates comprising a therapeutic compound conjugated to an oligomer, wherein the oligomer comprises a lipophilic moiety coupled to a hydrophilic moiety; therapeutic agents coupled to amphiphilic oligomers
10/18/2005US6956043 Pharmaceutical compositions comprising 33-epi-chloro-33-desoxy-ascomycin solid dispersions
10/18/2005US6956029 Solid formulation of glucosamine sulphate
10/18/2005US6956027 N-terminally chemically modified protein compositions and methods
10/18/2005US6956022 Increasing blood platelet formation by administering a parathyroid hormone or a derivative
10/18/2005US6956021 Stable spray-dried protein formulations
10/18/2005US6955898 Targeting pharmaceutical agents to injured tissues
10/18/2005US6955888 Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter
10/18/2005US6955825 Compositions and methods for high sorption of skin materials and delivery of sulfur
10/18/2005US6955823 forming dispersion of oil in water in presence of surfactant, heating above phase inversion temperature to form bicontinuous phase composition, cooling to below phase inversion temperature to form emulsion of oil drops in water, encapsulating
10/18/2005US6955822 Lactone bearing absorbable polymers
10/18/2005US6955821 Sustained release formulations of guaifenesin and additional drug ingredients
10/18/2005US6955818 for control of an external parasite on an animal of agricultural worth comprising 0.1 to 40% by weight of at least one spinosyn, and a non-irritant topically acceptable carrier, for example, tripropylene glycol methyl ether and benzyl alcohol
10/18/2005US6955639 Methods of enhancing radiation effects with metal nanoparticles
10/18/2005CA2340054C Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles
10/18/2005CA2282082C Microgranules containing cisplatin
10/18/2005CA2189521C Polymer blends containing absorbable polyoxaesters
10/18/2005CA2156288C Glycerol derivative, device and pharmaceutical composition
10/18/2005CA2106682C Viscous surface active composition
1 ... 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 ... 1712